Regeneron Pharmaceuticals (REGN) Change in Inventory (2013 - 2026)

Regeneron Pharmaceuticals has reported Change in Inventory for 14 years, with the latest figure at $28.2 million in Q2 2026.

• On a quarterly basis, Change in Inventory fell 33.65% year-over-year to $28.2 million in Q2 2026; TTM through Jun 2026 was $82.1 million, a 82.78% decrease from a year earlier, with the FY2025 full-year figure at $275.3 million, down 55.58% from the prior year.
• Change in Inventory was $28.2 million for Q2 2026 at Regeneron Pharmaceuticals, up from -$26.6 million in the prior quarter.
• The five-year high for Change in Inventory was $240.1 million in Q2 2022, with the low at -$26.6 million in Q1 2026.
• Average Change in Inventory over 5 years is $103.6 million, with a median of $94.5 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2026: Change in Inventory jumped 867.09% in 2022, then tumbled 117.47% in 2026.
• Over 5 years, Change in Inventory stood at $144.3 million in 2022, then slumped by 67.22% to $47.3 million in 2023, then surged by 148.84% to $117.7 million in 2024, then plunged by 101.78% to -$2.1 million in 2025, then jumped by 1442.86% to $28.2 million in 2026.
• The last three Change in Inventory figures came in at $28.2 million (Q2 2026), -$26.6 million (Q1 2026), and -$2.1 million (Q4 2025), per Business Quant data.